Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Judge, Andrew Robert	University Of Florida United States	The Complement System and Cancer Cachexia	5R01AR081648-04	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Justilien, Verline	Mayo Clinic Jacksonville United States	ECT2 Isoform Switch in Pancreatic Cancer.	1R21CA296671-01	Matthew Young, Ph.D.
Kachnic, Lisa A.	Columbia University Health Sciences United States	Columbia University NCI Community Oncology Research Program	3UG1CA189960-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kahalley, Lisa Schum	Baylor College Of Medicine United States	Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.	3R01CA249988-05S3	Rachel Altshuler, Ph.D.
Kalpathy-Cramer, Jayashree	University Of Colorado Denver United States	AI algorithm development for cervical cancer screening in low resource settings	1R21CA305472-01	Nicholas Hodges, Ph.D.
Kanarek, Naama	Boston Children'S Hospital United States	Mechanistic Study of Methotrexate-Induced Oxidative Distress in Neurons and the CSF	5R01CA282477-02	John Clifford, Ph.D.
Kanetsky, Peter A	H. Lee Moffitt Cancer Ctr & Res Inst United States	A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers	5R01CA291735-02	Claire Zhu, Ph.D.
Kang, Dongkyun	University Of Arizona United States	Non-invasive, quantitative microscopic biomarkers for chemotherapy-induced peripheral neuropathy	1R01CA301271-01	Rachel Altshuler, Ph.D.
Kanwal, Fasiha	Baylor College Of Medicine United States	Risk Stratification for and Early Detection of Liver Cancer	5U01CA230997-08	Sidney Fu, M.D.
Kassie, Fekadu	University Of Minnesota United States	Targeting tumor cell mitochondria for the prevention and treatment of lung cancer	1R01CA285608-01A1
Kelleher, Sarah	Duke University United States	Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings	5R21CA273832-02	Brennan Streck, Ph.D., RN, M.P.H.
Kelleher, Sarah	Duke University United States	Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients	5R01CA291888-02	Brennan Streck, Ph.D., RN, M.P.H.
Khan, Seema Ahsan	Northwestern University At Chicago United States	Determinants of transdermal drug delivery to the normal and the radiated breast	5R01CA235647-05	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Khan, Seema Ahsan	Northwestern University At Chicago United States	Northwestern Cancer Prevention Consortium	2UG1CA242643-07	Donald Johnsey
Khasabov, Sergey G	University Of Minnesota United States	Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling	5R01CA263777-05	Rachel Altshuler, Ph.D.

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants